The MD2-TLR4 pathway activates the MyD88-dependent MAPK and NF-κB pathways to induce pro-inflammatory cytokines [6], and has been regarded as one of the critical pathophysiological mechanisms of NAFLD [37,38]. This evidence concerns the gene LY96 and metabolic dysfunction-associated steatotic liver disease.